论文部分内容阅读
我院于1979年1月—1982年2月,用我院及中国医学科学院药物研究所从海南粗榧中提出的三尖杉酯碱和高三尖杉酯碱部分加用甲氨蝶呤或地塞米松作鞘内注射治疗中枢神经系统白血病40例,现将其疗效分析如下。 一般资料 1.年龄 最小5岁,最大52岁,其中30岁以下27例。 2.性别男29例,女11例。 3.细胞类型 急粒21例、慢粒急变5例、慢粒3例;急淋8例、慢淋急变1例,急性单核细胞型2例。
Our hospital in January 1979 - February 1982, with our hospital and the Institute of Materia Medica, Chinese Academy of Medical Sciences from the rough in Hainan proposed harringtonine and homoharringtonine plus part of the use of methotrexate or 40 cases of central nervous system leukemia treated by intrathecal injection of dexamethasone, and its efficacy are analyzed as follows. General information 1. The youngest 5 years old, maximum 52 years old, of which 27 cases under 30 years of age. Sex in 29 males and 11 females. There were 21 cases of acute type of cell type, 5 cases of chronic granulocyte blast crisis, 3 cases of chronic granuloma, 8 cases of acute lymphocytic leaching, 1 case of acute leprosy and 2 cases of acute monocytic cell.